1-3 of 3
Michael M Gottesman
Close
Sort by
Journal Articles

MAPK pathway activation leads to Bim loss and histone deacetylase inhibitor resistance: rationale to combine romidepsin with an MEK inhibitor

Arup R. Chakraborty, Robert W. Robey, Victoria L. Luchenko, Zhirong Zhan, Richard L. Piekarz, Jean-Pierre Gillet, Andrew V. Kossenkov, Julia Wilkerson, Louise C. Showe, Michael M. Gottesman, Nathan L. Collie, Susan E. Bates
Journal: Blood
Blood (2013) 121 (20): 4115–4125.
https://doi.org/10.1182/blood-2012-08-449140
Published: 2013
Includes: Supplemental data
Journal Articles

Individualized Multidrug Resistance In Acute Myeloid Leukemia

Chirayu Patel, Jean-Pierre Gillet, Leif Stenke, MD, PhD, Marita Lindberg, Magnus Bjorkholm, Jan Sjoberg, Kristina Viktorsson, Rolf Lewensohn, Ola Landgren, M.D., Ph.D., Michael M Gottesman
Journal: Blood
Blood (2010) 116 (21): 2491.
https://doi.org/10.1182/blood.V116.21.2491.2491
Published: 2010
Journal Articles

Engraftment of MDR1 and NeoR Gene-Transduced Hematopoietic Cells After Breast Cancer Chemotherapy

Jeffrey A. Moscow, Hui Huang, Charles Carter, Kenneth Hines, JoAnne Zujewski, Georgie Cusack, Cathy Chow, David Venzon, Brian Sorrentino, Yawen Chiang, Barry Goldspiel, Susan Leitman, Elizabeth J. Read, Andrea Abati, Michael M. Gottesman, Ira Pastan, Stephanie Sellers, Cynthia Dunbar, Kenneth H. Cowan
Journal: Blood
Blood (1999) 94 (1): 52–61.
https://doi.org/10.1182/blood.V94.1.52.413k35_52_61
Published: 1999